JAMESTOWN, RI -- (MARKET WIRE) -- 06/20/2006 -- BCR Diagnostics, a pioneer in spore-based biosensor technology, announced today that it has been selected by the National Institutes of Health to take part in the final stage of its Commercialization Assistance Program (NIH-CAP) called the Life Sciences Showcase.